Neurodevelopmental Outcomes in Early Adolescence: The Pediatric Heart Network’s Single Ventricle Reconstruction Trial

T Thomas A. Miller B Binu Sharma (Carelon Research, Wilmington, Delaware, United States) R Russell Gongwer (Carelon Research, Newton, MA (B.S., R.G., F.L.T.).) F Felicia L. Trachtenberg J Jane W. Newburger (Department of Cardiology, Boston Children’s Hospital, Harvard Medical School) C Caren S. Goldberg (Department of Pediatrics, University of Michigan, Ann Arbor (C.S.G.).) K Kathryn E. Gustafson (Departments of Psychiatry and Pediatrics, Duke University Medical Center, Durham, NC (K.E.G).) J J. William Gaynor (Division of Cardiothoracic Surgery, Children's Hospital of Philadelphia) J Jodie K. Votava-Smith L Linda M. Lambert (Division of Cardiothoracic Surgery, University of Utah/Primary Children’s Hospital, Salt Lake City (L.M.L.).) R Renee Sananes (Department of Psychology, Division of Cardiology, Hospital for Sick Children, Toronto, ON, Canada (R.S.).) M Mary C. Kral (Department of Pediatrics, Medical University of South Carolina, Charleston (M.C.K.).) R Rocky Tsang K Kimberley P. Heinrich (Neuropsychology Section, Department of Psychiatry, University of Michigan, Ann Arbor (K.P.H.).) J James Cnota (Cincinnati Childrens Hospital, Cincinnati, Ohio, United States) A Amee Shah D Dawn Ilardi (Department of Pediatrics, Emory University, Atlanta, GA (D.I.).)

Abstract

BACKGROUND: Neurodevelopmental and functional impairments are among the most consequential morbidities for survivors of hypoplastic left heart syndrome after staged single ventricle surgical palliation. The SVRIII trial (Long-Term Outcomes of Children With Hypoplastic Left Heart Syndrome and the Impact of Norwood Shunt Type) enrolled adolescents, who were randomized to different surgical shunt types at the time of Norwood procedure as neonates, for multifaceted in-person evaluation. This study reports their neurodevelopmental outcomes. METHODS: Transplant-free survivors from SVRIII were invited to complete an in-person comprehensive neurodevelopmental evaluation in early adolescence. Outcomes across domains of cognition, academics, learning, memory, and attention, as well as social, emotional, behavioral, adaptive, and executive function, were compared with those of normative populations. Associations with demographic and medical covariates, including Norwood shunt type, were also assessed. RESULTS: Among 549 participants enrolled in the SVR trial (Single Ventricle Reconstruction), 200 of the 237 SVRIII participants (84%) completed a neurodevelopmental evaluation at a mean age of 11 years (range, 10 to 14 years). SVRIII participants who did versus did not undergo evaluation were more likely to be male (63% versus 51%), to be White (87% versus 76%), and to have a higher Childhood Opportunity Index score (61±26 versus 46±39). Full-scale intelligence quotient (88±18) was significantly lower than in the normative population, with 39% >1 and 15% >2 SD below the normative mean. Similar patterns were seen for reading (38% >1 SD and 16% >2 SD below the normative mean) and math (38% >1 SD and 19% >2 SD below the normative mean) scores. Attention, executive functioning, social development, visual memory, and adaptive functioning were all more impaired than in the normative population. Measures of socioeconomic status, number of medical complications, and requirement for a gastrostomy tube were each independent predictors of neurodevelopment, with socioeconomic status the most consistently significant factor across models. Group differences by shunt type were inconsistent across neurodevelopmental domains without a clear benefit of one surgical strategy. CONCLUSIONS: In early adolescence, transplant-free survivors of surgical palliation for hypoplastic left heart syndrome show concerning impairments across all domains of neurodevelopment. The distribution of affected outcomes is broad and associated with demographic, medical, and, most frequently, socioeconomic factors. Our findings support recommendations for neurodevelopmental evaluation during adolescence to guide individualized interventions to promote educational success and psychosocial well-being. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02455531.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue 17
Published October 28, 2025
Pages 1246-1261
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (17)

T

Thomas A. Miller

B

Binu Sharma

Carelon Research, Wilmington, Delaware, United States

R

Russell Gongwer

Carelon Research, Newton, MA (B.S., R.G., F.L.T.).

F

Felicia L. Trachtenberg

J

Jane W. Newburger

Department of Cardiology, Boston Children’s Hospital, Harvard Medical School

C

Caren S. Goldberg

Department of Pediatrics, University of Michigan, Ann Arbor (C.S.G.).

K

Kathryn E. Gustafson

Departments of Psychiatry and Pediatrics, Duke University Medical Center, Durham, NC (K.E.G).

J

J. William Gaynor

Division of Cardiothoracic Surgery, Children's Hospital of Philadelphia

J

Jodie K. Votava-Smith

L

Linda M. Lambert

Division of Cardiothoracic Surgery, University of Utah/Primary Children’s Hospital, Salt Lake City (L.M.L.).

R

Renee Sananes

Department of Psychology, Division of Cardiology, Hospital for Sick Children, Toronto, ON, Canada (R.S.).

M

Mary C. Kral

Department of Pediatrics, Medical University of South Carolina, Charleston (M.C.K.).

R

Rocky Tsang

K

Kimberley P. Heinrich

Neuropsychology Section, Department of Psychiatry, University of Michigan, Ann Arbor (K.P.H.).

J

James Cnota

Cincinnati Childrens Hospital, Cincinnati, Ohio, United States

A

Amee Shah

D

Dawn Ilardi

Department of Pediatrics, Emory University, Atlanta, GA (D.I.).